The Sun rises in the landscape of treatment for patients ovarian carcinoma, inspired by the Review on p820.

Using mRNA–lipid nanoparticles in oncology, inspired by the Review on p739.

Delivering targeted therapies to brain metastases in patients with NSCLC, inspired by the Review on p716.

Antigen presentation in cancer, inspired by the Review on p604.

The various toxicities from antibody–drug conjugates, inspired by the Review on p558.

Role of gut microbiota in colorectal cancer, inspired by the Review on p429.

Activity of antibody–drug conjugates in brain tumours, inspired by the Review on p372.

Patient-derived organoids in precision oncology, inspired by the Review on p305.

Protein degraders enter the clinic, inspired by the Review on p265.

Oncolytic viruses as therapeutic agents, inspired by the Review on p160.

Thermal therapy-induced immunogenic cell death, inspired by the Review on p116.

Cell membrane-coated nanoparticles for targeted drug delivery, inspired by the Review on p33.